The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
Open accessAbstract
The Asia-Pacific Primary Liver Cancer Expert (APPLE) Consensus Statement on the treatment strategy for patients with intermediate-stage hepatocellular carcinoma (HCC) was established on August 31, 2019, in Sapporo, Hokkaido during the 10th Annual APPLE Meeting. This manuscript summarizes the international consensus statements developed at APPLE 2019. Transarterial chemoembolization (TACE) is the only guideline-recommended global standard of care for intermediate-stage HCC. However, not all patients benefit from TACE because intermediate-stage HCC is a heterogeneous disease in terms of tumor burden and liver function. Ten important clinical questions regarding this stage of HCC were raised, and consensus statements were generated based on high-quality evidence. In intermediate-stage HCC, preservation of liver function is as important as achieving a high objective response (OR) because the treatment goal is to prolong overall survival. Superselective conventional TACE (cTACE) is recommended as the first choice of treatment in patients eligible for effective (curative) TACE, whereas in patients who are not eligible, systemic therapy is recommended as the first choice of treatment. TACE is not indicated as the first-line therapy in TACE-unsuitable patients. Another important statement is that TACE should not be continued in patients who develop TACE failure/refractoriness in order to preserve liver function. Targeted therapy is the recommended first-line treatment for TACE-unsuitable patients. Especially, the drug, which can have higher OR rate, is preferred. Immunotherapy, transarterial radioembolization, TACE + targeted therapy or other modalities may be considered alternative options in TACE-unsuitable patients who are not candidates for targeted therapy. Better liver function, such as albumin-bilirubin grade 1, is an important factor for maximizing the therapeutic effect of systemic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Self-citationNormalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Self-citationMarrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Self-citationForner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Self-citationLlovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Johnson, P. J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H. L., O'Beirne, J., Fox, R., Skowronska, A., Palmer, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9151 · Cited by 2,783
Self-citationZhu, A. X., Finn, R. S., Edeline, J., Cattan, S., Ogasawara, S., Palmer, D., Verslype, C., Zagonel, V., Fartoux, L., Vogel, A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30351-6 · Cited by 2,479
Self-citationCabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A.-L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y., Park, J.-W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717002 · Cited by 2,344
Self-citationOmata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Self-citation(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-5-642_1 · Cited by 2,081
Mazzaferro, V., Llovet, J. M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Camerini, T., Roayaie, S., Schwartz, M. E., Grazi, G. L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70284-5 · Cited by 2,045
Molecular therapies and precision medicine for hepatocellular carcinoma
Llovet, J. M., Montal, R., Sia, D., & Finn, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0073-4 · Cited by 1,938
Finn, R. S., Ryoo, B.-Y., Merle, P., Kudo, M., Bouattour, M., Lim, H. Y., Breder, V., Edeline, J., Chao, Y., Ogasawara, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01307 · Cited by 1,789
Self-citationEvidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Zhu, A. X., Kang, Y.-K., Yen, C.-J., Finn, R. S., Galle, P. R., Llovet, J. M., Assenat, E., Brandi, G., Pracht, M., Lim, H. Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30937-9 · Cited by 1,662
Self-citationCammà, C., Schepis, F., Orlando, A., Albanese, M., Shahied, L., Trevisani, F., Andreone, P., Craxì, A., & Cottone, M. (2002) · Radiology · doi:10.1148/radiol.2241011262 · Cited by 851
Zhu, A. X., Park, J. O., Ryoo, B.-Y., Yen, C.-J., Poon, R., Pastorelli, D., Blanc, J.-F., Chung, H. C., Baron, A. D., Pfiffer, T. E. F., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00050-9 · Cited by 846
Self-citationVilgrain, V., Pereira, H., Assenat, E., Guiu, B., Ilonca, A. D., Pageaux, G.-P., Sibert, A., Bouattour, M., Lebtahi, R., Allaham, W., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30683-6 · Cited by 834
Kudo, M., Izumi, N., Kokudo, N., Matsui, O., Sakamoto, M., Nakashima, O., Kojiro, M., Makuuchi, M., & for the HCC Expert Panel of Japan Society of Hepatology (2011) · Digestive Diseases · doi:10.1159/000327577 · Cited by 825
Self-citationBruix, J., Raoul, J.-L., Sherman, M., Mazzaferro, V., Bolondi, L., Craxi, A., Galle, P. R., Santoro, A., Beaugrand, M., Sangiovanni, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.014 · Cited by 822
Kudo, M., Ueshima, K., Ikeda, M., Torimura, T., Tanabe, N., Aikata, H., Izumi, N., Yamasaki, T., Nojiri, S., Hino, K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318934 · Cited by 721
Self-citationChow, P. K. H., Gandhi, M., Tan, S.-B., Khin, M. W., Khasbazar, A., Ong, J., Choo, S. P., Cheow, P. C., Chotipanich, C., Lim, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.0892 · Cited by 658
Self-citationYau, T., Park, J. W., Finn, R. S., Cheng, A.-L., Mathurin, P., Edeline, J., Kudo, M., Han, K.-H., Harding, J. J., Merle, P., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz394.029 · Cited by 647
Self-citationMarrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., Heimbach, J. K., et al. (2019) · Clinical Liver Disease · doi:10.1002/cld.802 · Cited by 645
Burroughs, A., Dufour, J.-F., Galle, P., Mazzaferro, V., Piscaglia, F., Raoul, J., Sangro, B., & Bolondi, L. (2013) · Seminars in Liver Disease · doi:10.1055/s-0032-1329906 · Cited by 641
Tohyama, O., Matsui, J., Kodama, K., Hata-Sugi, N., Kimura, T., Okamoto, K., Minoshima, Y., Iwata, M., & Funahashi, Y. (2014) · Journal of Thyroid Research · doi:10.1155/2014/638747 · Cited by 475
Korean Liver Cancer Association, K., & National Cancer Center, N. (2019) · Gut and Liver · doi:10.5009/gnl19024 · Cited by 391
Pathology of small hepatocellular carcinoma. A proposal for a new gross classification
Kanai, T., Hirohashi, S., Upton, M. P., Noguchi, M., Kishi, K., Makuuchi, M., Yamasaki, S., Hasegawa, H., Takayasu, K., Moriyama, N., et al. (1987) · Cancer · doi:10.1002/1097-0142(19870815)60:4<810::aid-cncr2820600417>3.0.co;2-1 · Cited by 358
Hiraoka, A., Michitaka, K., Kumada, T., Izumi, N., Kadoya, M., Kokudo, N., Kubo, S., Matsuyama, Y., Nakashima, O., Sakamoto, M., et al. (2017) · Liver Cancer · doi:10.1159/000479984 · Cited by 331
Self-citationKudo, M., Ueshima, K., Chan, S., Minami, T., Chishina, H., Aoki, T., Takita, M., Hagiwara, S., Minami, Y., Ida, H., et al. (2019) · Cancers · doi:10.3390/cancers11081084 · Cited by 309
Self-citationKudo, M., Ueshima, K., Yokosuka, O., Ogasawara, S., Obi, S., Izumi, N., Aikata, H., Nagano, H., Hatano, E., Sasaki, Y., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30078-5 · Cited by 305
Self-citationWang, B., Xu, H., Gao, Z. Q., Ning, H. F., Sun, Y. Q., & Cao, G. W. (2008) · Acta Radiologica · doi:10.1080/02841850801958890 · Cited by 285
Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
Kudo, M., Matsui, O., Izumi, N., Kadoya, M., Okusaka, T., Miyayama, S., Yamakado, K., Tsuchiya, K., Ueshima, K., Hiraoka, A., et al. (2014) · Oncology · doi:10.1159/000368142 · Cited by 283
Self-citationGolfieri, R., Cappelli, A., Cucchetti, A., Piscaglia, F., Carpenzano, M., Peri, E., Ravaioli, M., D'Errico-Grigioni, A., Pinna, A. D., & Bolondi, L. (2011) · Hepatology · doi:10.1002/hep.24246 · Cited by 264
Yamashita, T., Kudo, M., Ikeda, K., Izumi, N., Tateishi, R., Ikeda, M., Aikata, H., Kawaguchi, Y., Wada, Y., Numata, K., et al. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-019-01642-1 · Cited by 229
Self-citationKudo, M., Arizumi, T., Ueshima, K., Sakurai, T., Kitano, M., & Nishida, N. (2015) · Digestive Diseases · doi:10.1159/000439290 · Cited by 225
Self-citationLencioni, R., Montal, R., Torres, F., Park, J.-W., Decaens, T., Raoul, J.-L., Kudo, M., Chang, C., Ríos, J., Boige, V., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.012 · Cited by 224
Self-citationKim, B. K., Kim, S. U., Kim, K. A., Chung, Y. E., Kim, M.-J., Park, M.-S., Park, J. Y., Kim, D. Y., Ahn, S. H., Kim, M. D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.022 · Cited by 202
Self-citationOgasawara, S., Chiba, T., Ooka, Y., Kanogawa, N., Motoyama, T., Suzuki, E., Tawada, A., Kanai, F., Yoshikawa, M., & Yokosuka, O. (2014) · Oncology · doi:10.1159/000365993 · Cited by 180
Hiraoka, A., Kumada, T., Atsukawa, M., Hirooka, M., Tsuji, K., Ishikawa, T., Takaguchi, K., Kariyama, K., Itobayashi, E., Tajiri, K., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2241 · Cited by 161
Self-citationKudo, M. (2019) · Liver Cancer · doi:10.1159/000502905 · Cited by 160
Self-citationHiraoka, A., Kumada, T., Kudo, M., Hirooka, M., Koizumi, Y., Hiasa, Y., Tajiri, K., Toyoda, H., Tada, T., Ochi, H., et al. (2017) · Digestive Diseases · doi:10.1159/000480256 · Cited by 153
Self-citationVincenzi, B., Maïo, M. D., Silletta, M., D’Onofrio, L., Spoto, C., Piccirillo, M. C., Daniele, G., Comito, F., Maci, E., Bronte, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133488 · Cited by 150
Ueshima, K., Nishida, N., Hagiwara, S., Aoki, T., Minami, T., Chishina, H., Takita, M., Minami, Y., Ida, H., Takenaka, M., et al. (2019) · Cancers · doi:10.3390/cancers11070952 · Cited by 138
Self-citationHiraoka, A., Kumada, T., Kariyama, K., Takaguchi, K., Atsukawa, M., Itobayashi, E., Tsuji, K., Tajiri, K., Hirooka, M., Shimada, N., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1909 · Cited by 131
Kano, M. R., Komuta, Y., Iwata, C., Oka, M., Shirai, Y.-T., Morishita, Y., Ouchi, Y., Kataoka, K., & Miyazono, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01003.x · Cited by 125
Golfieri, R., Renzulli, M., Mosconi, C., Forlani, L., Giampalma, E., Piscaglia, F., Trevisani, F., & Bolondi, L. (2013) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2012.12.013 · Cited by 115
Zen, C., Zen, Y., Mitry, R. R., Corbeil, D., Karbanová, J., O’Grady, J., Karani, J. B., Kane, P., Heaton, N. D., Portmann, B. C., et al. (2011) · Liver Transplantation · doi:10.1002/lt.22314 · Cited by 101
Peck‐Radosavljevic, M., Kudo, M., Raoul, J., Lee, H. C., Decaens, T., Heo, J., Lin, S., Shan, H., Yang, Y., Bayh, I., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.4018 · Cited by 95
Self-citationOgasawara, S., Chiba, T., Ooka, Y., Suzuki, E., Kanogawa, N., Saito, T., Motoyama, T., Tawada, A., Kanai, F., & Yokosuka, O. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0292-9 · Cited by 83
Hiraoka, A., Kumada, T., Atsukawa, M., Hirooka, M., Tsuji, K., Ishikawa, T., Takaguchi, K., Kariyama, K., Itobayashi, E., Tajiri, K., et al. (2019) · Oncology · doi:10.1159/000501281 · Cited by 82
Self-citationMeyer, T., Palmer, D. H., Cheng, A., Hocke, J., Loembé, A., & Yen, C. (2017) · Liver International · doi:10.1111/liv.13359 · Cited by 76
Self-citationKudo, M. (2018) · Liver Cancer · doi:10.1159/000492533 · Cited by 69
Self-citationYasui, Y., Tsuchiya, K., Kurosaki, M., Takeguchi, T., Takeguchi, Y., Okada, M., Wang, W., Kubota, Y., Gotō, T., Komiyama, Y., et al. (2017) · Hepatology Research · doi:10.1111/hepr.13048 · Cited by 66
Arizumi, T., Ueshima, K., Chishina, H., Kono, M., Takita, M., Kitai, S., Inoue, T., Yada, N., Hagiwara, S., Minami, Y., et al. (2014) · Oncology · doi:10.1159/000368143 · Cited by 55
Self-citationArizumi, T., Minami, T., Chishina, H., Kono, M., Takita, M., Yada, N., Hagiwara, S., Minami, Y., Ida, H., Ueshima, K., et al. (2017) · Digestive Diseases · doi:10.1159/000480208 · Cited by 55
Self-citationKimura, H., Ohkawa, K., Miyazaki, M., Sakakibara, M., Imanaka, K., Tamura, T., Sueyoshi, H., Takada, R., Fukutake, N., Uehara, H., et al. (2016) · Hepatology International · doi:10.1007/s12072-016-9771-0 · Cited by 52
Kawamura, Y., Kobayashi, M., Shindoh, J., Kobayashi, Y., Kasuya, K., Sano, T., Fujiyama, S., Hosaka, T., Saitoh, S., Sezaki, H., et al. (2020) · Liver Cancer · doi:10.1159/000505190 · Cited by 49
Kudo, M., Finn, R. S., Qin, S., Han, K., Ikeda, K., Cheng, A., Piscaglia, F., Ueshima, K., Aikata, H., Vogel, A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.4_suppl.186 · Cited by 47
Self-citationHeterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B
Chow, P. K. H., Choo, S. P., Ng, D. C. E., Lo, R. H. G., Wang, M. L. C., Toh, H. C., Tai, D. W. M., Goh, B. K. P., Wong, J. S., Tay, K. H., et al. (2016) · Liver Cancer · doi:10.1159/000367768 · Cited by 41
Self-citationYamashita, Y., Matsukawa, T., Arakawa, A., Hatanaka, Y., Urata, J., & Takahashi, M. (1995) · Radiology · doi:10.1148/radiology.196.3.7644646 · Cited by 35
Kawamura, Y., Kobayashi, M., Shindoh, J., Kobayashi, Y., Kasuya, K., Sano, T., Fujiyama, S., Hosaka, T., Saitoh, S., Sezaki, H., et al. (2019) · Liver Cancer · doi:10.1159/000503577 · Cited by 34
Zhang, Y., Zhang, M., Chen, M., Mei, J., Xu, L., Guo, R., Lin, X., Li, J., & Peng, Z. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3213 · Cited by 29
Kudo, M., Ueshima, K., Chiba, Y., Ogasawara, S., Obi, S., Izumi, N., Aikata, H., Nagano, H., Hatano, E., Sasaki, Y., et al. (2019) · Liver Cancer · doi:10.1159/000503032 · Cited by 26
Self-citationEso, Y., Takai, A., Takahashi, K., Ueda, Y., Taura, K., Marusawa, H., & Seno, H. (2019) · Cancers · doi:10.3390/cancers11030405 · Cited by 25
Izumoto, H., Hiraoka, A., Ishimaru, Y., Murakami, T., Kitahata, S., Ueki, H., Aibiki, T., Okudaira, T., Miyamoto, Y., Yamago, H., et al. (2017) · Oncology · doi:10.1159/000481242 · Cited by 24
Self-citationOkusaka, T., Ikeda, K., Kudo, M., Finn, R. S., Qin, S., Han, K., Cheng, A., Piscaglia, F., Kobayashi, M., Sung, M. W., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01785-0 · Cited by 19
Self-citationPeck‐Radosavljevic, M., Lee, H. C., Kudo, M., Nakajima, K., Bayh, I., Cheng, A., & Raoul, J. (2019) · Journal of Hepatology · doi:10.1016/s0618-8278(19)31229-0 · Cited by 4
Self-citation
Cited by
Singal, A. G., Kanwal, F., & Llovet, J. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00825-3 · Cited by 951
Kudo, M., Kawamura, Y., Hasegawa, K., Tateishi, R., Kariyama, K., Shiina, S., Toyoda, H., Imai, Y., Hiraoka, A., Ikeda, M., et al. (2021) · Liver Cancer · doi:10.1159/000514174 · Cited by 678
Self-citationLi, Q.-J., He, M.-K., Chen, H.-W., Fang, W.-Q., Zhou, Y.-M., Xu, L., Wei, W., Zhang, Y.-J., Guo, Y., Guo, R.-P., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.00608 · Cited by 420
Kudo, M., Ren, Z., Guo, Y., Han, G., Lin, H., Zheng, J., Ogasawara, S., Kim, J. H., Zhao, H., Li, C., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02575-3 · Cited by 342
Self-citation
Metadata
- Authors
- Kudo, M., Han, K.-H., Ye, S.-L., Zhou, J., Huang, Y.-H., Lin, S.-M., Wang, C.-K., Ikeda, M., Chan, S. L., Choo, S. P., Miyayama, S., Cheng, A. L., & on behalf of the APPLE Association
- Venue
- Liver Cancer
- Publisher
- S. Karger AG
- Published
- 2020
- Volume
- 9
- Issue
- 3
- Pages
- 245-260
- ISSN
- 1664-5553 (ISSN-L)
- 2235-1795
- OpenAlex
- W3025742326
- Cited by
- 314
- References
- 74
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.